Functional significance of MMP-9 in tumor necrosis factor-induced proliferation and branching morphogenesis of mammary epithelial cells

Endocrinology

Volumn 141, Issue 10, 2000, Pages 3764-3773

  Lee, Ping Ping H ^a   Hwang, Jiuan Jiuan ^b   Murphy, Gillian ^c   Ip, Margot M ^a,d  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^d ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; MATRIX METALLOPROTEINASE INHIBITOR; TUMOR NECROSIS FACTOR;

ADOLESCENT; ANIMAL CELL; ARTICLE; BREAST CANCER; BREAST DEVELOPMENT; BREAST EPITHELIUM; CELL INVASION; CELL PROLIFERATION; CELL STRUCTURE; CONCENTRATION RESPONSE; EPITHELIUM CELL; MORPHOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RAT;

EID: 0033752746     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.141.10.7697     Document Type: Article

References (57)

1. Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression
2. Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misreglulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development
3. The role of metalloproteinases and their inhibitors in regulating mammary epithelial morphology and function in vivo
4. Joint destruction in arthritis: Metalloproteinases in the spotlight
5. Tumor cell interactions with the extracellular matrix during invasion and metastasis
6. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
7. Roles of the matrix metalloproteinases in mammary gland development and cancer
8. The activation of human type IV collagenase proenzyme
9. Zinc coordination, function and structure of zinc enzymes and other proteins
10. The cysteine switch: A principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family
11. Structure of the human type IV collagenase gene
12. Complete structure of the human gene for 92-kDa type IV collagenase: Divergent regulation of expression for the 92- and 72-kDa enzyme genes in HT-1080 cells
13. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells
14. Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro
15. Matrix metalloproteinases MMP2 and MMP9 are produced in early stages of kidney morphogenesis but only MMP9 is required for renal organogenesis in vitro
16. Neutral proteinases of human mononuclear phagocytes: Cellular differentiation markedly alters cell phenotype for serine proteinases, metalloproteinases and tissue inhibitor of metalloproteinases
17. TNF-α and IL-1 β selectively induce expression of 92-kDa gelatinase by human macrophages
18. Identification of 92-kD gelatinase in human coronary atherosclerotic lesions: Association of active enzyme synthesis with unstable angina
19. Constitutive expression of a 92-kD gelatinase (type V collagenase) by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines
20. Induction and stimulation of 92-kDa gelatinase/type IV collagenase production in osteosarcoma and fibrosarcoma cell lines by tumor necrosis factor α
21. Tumor necrosis factor alpha and lymphotoxin stimulate human myeloblastic leukemia cell (ML-1) invasion through a reconstituted basement membrane (matrigel) with concomitant induction of 92 kDa gelatinase secretion
22. 1 integrin in HL-60 cells
23. Inhibitory effect of TNF α antibodies on synovial cell IL-1 production in rheumatoid arthritis
24. Expression of granulocyte-macrophage colony stimulating factor (GM-CSF) in rheumatoid arthritis: Regulation by tumor necrosis factor α
25. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis
26. Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis
27. Inhibition of cartilage and bone destruction in adjuvant arthritis in the rat by a matrix metalloproteinase inhibitor
28. Preclinical antiarthritic activity of MMP inhibitors
29. The tumor necrosis factor ligand and receptor families
30. An endotoxin-induced serum factor that causes necrosis of tumors
31. TNF in combination with interferon-γ is cytotoxic to normal, untransformed mouse and rat embryo fibroblast-like cells
32. Tumor necrosis factor-α: A multifunctional regulator of mammary gland development
33. Regulation of rat mammary epithelial cell proliferation and differentiation by tumor necrosis factor-α
34. The epidermal growth factor receptor is not required for tumor necrosis factor-α action in normal mammary epithelial cells
35. Disrupted mammary gland development in TNFα knockout mice
36. Primary culture of normal rat mammary epithelial cells within a basement membrane matrix. I. Regulation of proliferation by hormones and growth factors
37. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates
38. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
39. Inhibition of tumor cell invasion by a highly conserved peptide sequence from the matrix metalloproteinase enzyme prosegment
40. Inhibition of AIDS-Kaposi's sarcoma cell induced endothelial cell invasion by TIMP-2 and a synthetic peptide from the metalloproteinase propeptide: Implications for an anti-angiogenic therapy
41. Batimastat, a potent matrix metalloproteinase inhibitor, exhibits an unexpected mode of binding
42. Discovery of CGS 27023A, a non-peptidic, potent and orally active stromelysin inhibitor that blocks carthage degradation in rabbits
43. Mutational analysis of the transin (rat stromelysin) autoinhibitor region demonstrates a role for residues surrounding the 'cysteine switch.'
44. A 96 kDa gelatinase induced by TNF-α contributes to increased microvascular endothelial permeability
45. Matrix metalloproteinase-9 (92 kDa gelatinase/type IV collagenase) from U937 monoblastoid cells: Correlation with cellular invasion
46. Matrix metalloproteinase inhibition as a novel anticancer strategy: A review with special focus on batimastat and marimastat
47. Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice
48. Phase 1 trial of a novel matrix metalloproteinase inhibitor batimastat (BB-94) in patients with advanced cancer
49. The matrix metalloproteinase inhibitor batimastat (BB-94) retards human breast cancer solid tumor growth but not ascites formation in nude mice
50. Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94)
51. A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts
52. Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor
53. Paradoxical effects of a synthetic metalloproteinase inhibitor that blocks both P55 and P75 TNF receptor shedding and TNFα processing in RA synovial membrane cell cultures
54. Processing of tumour necrosis factor-α precursor by metalloproteinases
55. Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor
56. Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing
57. Synthetic matrix metalloproteinase inhibitors and tissue inhibitor of metalloproteinase (TIMP)-2, but not TIMP-1, inhibit shedding of tumor necrosis factor-α receptors in a human colon adenocarcinoma (Colo 205) cell line